PRODIGE 52 -UCGI 29-CCTG/CO.27 (IROCAS) A multicenter, international, randomized phase III trial comparing adjuvant modified (m)FOLFIRINOX to mFOLFOX6 in patients
with high-risk stage III (pT4 and/or N2) colon cancer (A UNICANCER GI-PRODIGE trial)
ANNÉE
2018
AUTEURS
Bennouna J, Andre T, Miglianico L, Campion L, Mineur L, Heng Lam Y, Hire St, Artru P, Bouche O, Borde F, Aleba A, Rajpar LS, Rebischung C, Touchefeu Y, Kavan P, Gill S, Asmis T, JouffroyZeller C, Emile JF, Taieb J
CONGRÈS/REVUE
ASCO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES